K&L Gates Adds Healthcare and AI Governance Partner in Washington, DC

18 November 2026

Washington, DC – Global law firm K&L Gates LLP welcomes Jay Mitchell as a partner in its Healthcare and FDA practice group. Mitchell joins K&L Gates’ Washington, DC office from Leidos QTC Health Services, where he served as Vice President and Senior Assistant General Counsel.

During his tenure at Leidos QTC Health Services, Mitchell led the legal and compliance function for a large healthcare business serving federal healthcare programs and commercial clients nationwide and internationally, supporting millions of medical examinations annually. He advised executive leadership on healthcare regulatory and contractual compliance, privacy, cybersecurity and enterprise risk, while strengthening risk management processes, governance, and reporting. Before moving in-house, Mitchell spent a decade practicing at leading global law firms, advising multinational companies and their boards on regulatory compliance, litigation, and investigations.

Mitchell continues to advise companies on healthcare regulatory compliance, privacy and cybersecurity, and the legal issues arising from the development and use of emerging technologies. Drawing on his experience in both private practice and in-house legal leadership, he helps clients navigate healthcare regulatory obligations, manage sensitive data, and structure commercial relationships in highly regulated industries. His practice includes HIPAA and federal healthcare program requirements; federal and state privacy laws, including the California Consumer Privacy Act (CCPA); data breach assessment and incident response; and AI governance. He also counsels clients on digital health and AI-enabled products and services, health data governance, and technology and commercial transactions, including customer, vendor, government, and healthcare provider agreements involving data use, HIPAA business associate agreements, and cybersecurity obligations. His experience also encompasses regulatory investigations, litigation, and enterprise risk management.

Michael Scanlon, lead practice area leader of K&L Gates’ global Policy & Regulatory practice, said: “Jay brings a valuable combination of sophisticated healthcare regulatory knowledge, technology experience, and a thoughtful perspective informed by his previous in-house roles. His background advising businesses at the intersection of healthcare, data, cybersecurity, and emerging technologies will further strengthen the capabilities we provide to clients navigating increasingly complex regulatory environments. His AI governance experience adds a practical, timely perspective for clients working with AI-enabled healthcare services.”

David Wochner, managing partner of the firm’s Washington, DC office and Regional Managing Partner for the United States, commented: “We are delighted to welcome Jay to the firm. His experience leading an in-house legal and compliance function for a business serving federal healthcare programs brings a practical understanding of how regulations affect day-to-day operations. His insights complement the strengths of our Washington, DC office in critical regulated industries and position him to collaborate across practices for clients navigating federal regulatory obligations and complex business challenges.”

Mitchell’s arrival adds to the strategic growth of the firm’s Washington, DC office over the last year. Recent additions include FDA and life sciences partner Christine Kirk, government affairs advisor Emily Lavery and government affairs counselor Hayden Haynes, former Chief of Staff for US Speaker of the House Mike Johnson. The practice also welcomed Washington, DC partner Sanjeev Bhasker, who formerly served as the Department of Justice’s US Digital Currency Counsel, and partner Jeremy Huffman, an international trade and national security lawyer. Within the firm’s Asset Management and Investment Funds practice, K&L Gates also added partner Tim Foley and partner Thoreau Bartmann to its Washington, DC office earlier this year. They are among the nearly 35 partners and of counsel to join the firm globally since the beginning of the year.

Mitchell commented: “Healthcare and technology companies are navigating increasingly complex regulatory requirements as they adopt new technologies, manage sensitive data, and deliver services at scale. My background combines experience at leading global law firms with in-house legal and compliance leadership for a business serving federal healthcare programs and commercial clients. At K&L Gates, I look forward to helping clients address these challenges with practical legal advice that accounts for both regulatory obligations and business realities, particularly in healthcare, privacy, cybersecurity, and AI governance.”

Lawyers in K&L Gates’ Healthcare and FDA practice have decades of experience effectively addressing the issues and problems that arise for healthcare providers, including health systems, academic medical centers, and pharmacies. The team provides advice regarding regulatory issues, fraud, and abuse issues, as well as payor disputes and contracting.